1a8 apccy7

Manufactured by Thermo Fisher Scientific

1A8-APCCy7 is a fluorescent dye-conjugated antibody product manufactured by Thermo Fisher Scientific. It is a tool used for cell analysis and identification in various research applications.

Automatically generated - may contain errors

Lab products found in correlation

Luminol, by Biosynth (1 mentions) F4 80 apc, by Thermo Fisher Scientific (1 mentions) Cd11c pe cy7, by Thermo Fisher Scientific (1 mentions) Cd45 percp cy5, by BD (1 mentions) Anti il 4 fitc, by BD (1 mentions) Cd11b pb, by Thermo Fisher Scientific (1 mentions) Ly6c fitc, by Thermo Fisher Scientific (1 mentions) Gr1 apc, by Thermo Fisher Scientific (1 mentions) Cd45 apc, by BD (1 mentions) Anti ifn γ pe cy7, by BD (1 mentions) Cd8 apc, by BD (1 mentions)

1 protocol using 1a8 apccy7

Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

Stained cells were analyzed using a BD LSR II-SORP system (Becton Dickinson) and analyzed with FlowJo software (Tree Star). The following mAbs were used: CD45-PerCPCy5, CD45-APC, CD8-APC, anti-IFNγ-PECy7 and anti-IL-4-FITC (BD Biosciences), Gr1-APC, CD11c-PECy7, CD11b-PB, F4/80-APC (eBiosciences), 1A8-APCCy7, Ly6C-FITC, 1A8-APCCy7, CD4-AF700. DAPI and AnV-FITC (BioLegends). In vivo bioluminescence imaging of MPO activity was quantified through injection of 200mg/kg luminol (Carbosynth) i.p. 10 minutes before luminescence acquisition. Photon emission was acquired for 10 minutes using a Xenogen IVIS Imaging system.

Hurrell B.P., Schuster S., Grün E., Coutaz M., Williams R.A., Held W., Malissen B., Malissen M., Yousefi S., Simon H.U., Müller A.J, & Tacchini-Cottier F. (2015). Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion. PLoS Pathogens, 11(5), e1004929.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!